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C oncepts such as clinical complexity, multimorbidity,severity of illness, and disease burden seek to charac-
terize the subset of patients whose severity and/or number of
illnesses disproportionately affect their lives. We see many
such patients in our clinics and in our hospitals. As the
numbers of these patients grow, with escalating health care
costs and utilization, it is increasingly urgent to answer the
following questions: Are these clinically complex patients
receiving quality care? Are they satisfied with their experience
with the health care system? How can we best measure these
important domains and ensure that quality measures ade-
quately are directing providers and health systems to prioritize
attention and resources to the most important areas for these
patients? These issues, while important for all patients, are
especially critical for clinically complex patients.
The paper by Werner and Chang both adds to our under-
standing of these issues as well as highlights some of the
technical problems in attempting to answer questions of
quality of care and patient satisfaction1. Werner and Chang
build on recent work on the impact of performance measure-
ment on clinically complex patients in two important ways.
Several recent papers have documented that clinically complex
patients are more likely than less complex patients to receive
recommended care2,3, but in prior research frequency of
medical visits was either not assessed or, in at least one
study3, did not affect the independent relationship between
multimorbidity and quality of care. In contrast, Werner and
Change found that higher quality of care was mediated by
increased frequency of medical visits. In multivariate analyses
controlling for visit frequency, higher clinical complexity was
associated with lower odds of receiving recommended process-
es of care more often than expected. Second, they found that
satisfaction with care was higher among clinically complex
patients with high measured performance of recommended
processes of care. This finding suggests that compliance with
performance measures was not crowding out other aspects of
care valued by these patients. This is an important finding,
since as they note, if a patient has needs that lie outside of the
measured conditions, performance measures may ‘crowd out’
unmeasured care by creating incentives for physicians to
attend to measured medical problems over unmeasured
ones.
This line of research, however, raises a number of technical
issues particularly germane to complex patients and highlights
many of the clinical management issues facing such patients
and their physicians. We will address a number of the
technical issues and then suggest an approach to such
patients that we believe will ultimately prove to be of increased
value to both the patient and their physicians.
The first technical question is the mechanisms by which
increased medical visits influence both quality of care and
patient satisfaction. As the authors hypothesize, does seeing a
single physician frequently give that doctor more opportunities
to successfully address all the many competing demands of
clinical complexity and still meet performance measures? It is
also possible that this observed effect is mediated by seeing
multiple physicians, each of whom has a different area of
clinical emphasis and potential to ‘catch’ omissions of other
doctors. Another possibility is the role of clinical systems
beyond the actions of individual physicians. The Veterans
Affairs (VA) health system studied in this paper is in the
forefront of developing systems to monitor chronic conditions
and ensure, through electronic health record alerts, mandato-
ry intake nurse check lists, and other methods that patients
with those conditions receive the necessary screening, treat-
ment, and follow-up. Maybe this is a success of more frequent
interaction with the infrastructure we are trying to institute
under the Advanced Medical Home concept– and not just
increased interactions with the physician. As with all good
research the results often trigger many more important
questions.
The next technical question is the definition of clinical
complexity itself. In Werner and Chang’s paper they defined
clinical complexity by the anticipated cost of caring for patients
with specified diagnoses using the listed patients’ aggregated
diagnoses in the Diagnostic Cost Groups (DCG) Hierarchical
Condition Categories model4. This model uses diagnoses to
develop an “expected” cost based on patients with similar
diagnoses. This expected cost definition of clinical complexity
might not be congruent with other potential definitions of
complexity. Perhaps patients who have frequent clinic visits
have more diagnoses documented and therefore have higher
complexity or “expected” cost. Or perhaps documenting the
diagnosis leads to screening or therapeutic “next steps”. The
same issue would be evident whether the definition of com-
plexity was cost or number of diagnoses identified. The act of
having more visits may indicate either more clinical need or it
might just result in more documentation leading to a higher
apparent clinical complexity.
The issue of circularity in definitions of clinical complexity
and performance measures may seem a little persnickety, but
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the results of one of the main outcomes in the Werner article,
patient satisfaction, runs counter to a body of literature
exploring the relationship between other important indications
of disease burden, a patient’s self-reported health and func-
tional status, and satisfaction with care. In most prior studies,
including those in VA settings, patients with lower self-
reported health and functional scores have been shown to
have lower global satisfaction with their medical care5–7. The
author’s definition of clinical complexity did not incorporate
patients’ own assessments of their health and functional
status. Perhaps these differences in results can be partially
explained by the circularity of relying on diagnoses both to
define the complexity of the cases and the outcomes to be
assessed.
It is indeed reassuring that compliance with current
performance measures did not negatively impact clinically
complex patients’ global satisfaction with their health care
received at the VA. Yet, still unanswered is whether these
performance measures indeed are capturing the most clinical-
ly relevant and highest-priority areas for these clinically
complex patients. The difficulty in exploring the important
domains of quality and satisfaction among patients with
chronic conditions is compounded by the reliance on simplistic
and clinically irrelevant and/or potentially harmful “standards
of care”8,9. If we are to move to a clinically nuanced under-
standing of high quality care we must move beyond the every
patient is a “747 awaiting takeoff” mentality. The one-size-fits-
all checklist-driven approach that quality and patient safety
groups have embraced may in some cases be detrimental to
both quality and patient safety10. Patients with multiple
conditions have multiple and interacting conditions. For
example, the ACE inhibitor for a patient’s heart failure (HF)
might not be the optimal choice in the face of their concomitant
chronic renal insufficiency, even though it is on the checklist of
process measures for patients with HF. When confronted with
a patient with five or six interacting chronic conditions, how do
we prioritize from among the six different checklists of “quality
process measures” and still have the patient (or us) under-
stand how best to improve their health until their next visit?
The real question is, “Given this patient’s multiple conditions
and the current evidence on these conditions, how can we
optimize the patient’s global health state today?” “How do we
help this patient prioritize from among the many issues and
focus on the subset that will be of most value to her?” This
can’t be found on a checklist. It can, however, be found in the
voluminous clinical information available for most patients
with severe and multiple chronic conditions.
To best help our patients with clinically complex conditions,
we need to move from a checklist filled with “to dos” and
simplistic dichotomous cut-offs that identify clinical “success”
or “failure” to longitudinal, weighted measures that give more
credit for high-priority care than low-priority care and are
personalized for each patient. We now have the statistical tools,
and emerging information infrastructure in health systems
such as the VA and other integrated systems, to create
multivariate risk-stratified profiles of medical conditions11–13.
We can then use these models and the patient’s own diagno-
ses, medications, visits, and laboratory values, as well as
history of prior treatment intolerances and failures, to develop
an action list for each patient, for each visit. We are beginning
to see the results of such analyses. For example, this approach
has demonstrated the importance of blood pressure control
and its influence on cardiovascular risk in adults with
diabetes14.
By focusing on a select number of high-value interventions,
one can better focus within the 15-minute outpatient visit on
items that are both of most clinical importance and to address
the preferences of clinically complex patients. This approach
can at the same time that it optimizes care minimize both the
cost and unintended consequences of the checklist-based,
one-size-fits-all approach. The development of such measures
incorporating clinically-detailed information will require polit-
ical will and resources to create the necessary integrated
medical information systems in many health care settings.
Werner and Chang rightly highlight the crucial question of
whether current performance measurement is crowding out
areas of most concern to clinically complex patients. It is of
equal importance to ensure that current performance mea-
sures are not ‘crowding out’ areas of higher clinical priority for
individual patients than what is currently measured.
In summary, the paper by Werner and Chang makes an
important contribution to the growing literature on quality of
care and satisfaction measurement among clinically complex
patients. We point out some of the current difficulties with this
field both operationally and conceptually. We highlight the
need for a paradigm shift in the field, to make use of the wealth
of data, information systems, and statistical methods to guide
the care of each of our clinically complex patients. In the era of
value-based health care, we must take the lead and ensure
that our sickest patients receive our most informed and
directed care. We must move from a uniform list of “to dos” to
a plan of directed improvement, tailored to each of our
clinically complex patients. Care that targets the highest
priorities for each patient needs to be the new definition of
quality of care for our clinically complex patients!
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